LONDON (Reuters) - A copy of the blockbuster biotech drug Enbrel was recommended for approval in Europe on Friday, making it the second so-called biosimilar antibody medicine to win such a green light ...
A Colorado board voted unanimously Feb. 16 to consider setting a maximum price for a drug to treat autoimmune diseases, launching the state into uncharted territory and setting up a possible showdown ...
A drugmaker whose product could be the first subjected to a price cap in Colorado is suing to throw out the state board that deemed its medication unaffordable. In February, the Colorado Prescription ...
A state board in Colorado is working to make history by becoming the first in the country to cap the price of a drug it deems unaffordable. Amid an aggressive industry lobbying campaign, Colorado ...
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...
Amgen has four specific complaints with a new state-level drug pricing measure in Colorado. (Al Seib/Los Angeles Times/Getty Images) Amgen’s arthritis blockbuster Enbrel already owns an undesirable ...
The U.S. Supreme Court decided not to take up Sandoz's last-ditch Enbrel biosimilar petition. ((Getty/BrianPIrwin)) After back-to-back losses in court, Novartis’ generics outfit Sandoz had hoped the U ...
Sofusa is a drug delivery platform technology which delivers biologic therapies through the skin directly into the lymphatic system with potential to improve efficacy and safety and reduce the ...
Getting your Trinity Audio player ready... A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results